Photocurable Composition

Publication: EP3771471A1
Published: 2021-02-03
Family Size: 5
Granted: Yes (1/5)

Simple SummaryContent extracted from patent full text and abstract with AI.

This patent describes a novel photocurable composition ("resin") specifically designed for 3D printing, particularly stereolithography (SLA). The composition uses functionalized gelatin and/or decellularized extracellular matrix (dECM) as photocrosslinkable prepolymers, formamide as a unique solvent to ensure proper dissolution and optimal printability, and a photoinitiator for polymer crosslinking when exposed to light. The addition of functionalized poly(ε-caprolactone) (PCL) improves print resolution and mechanical properties. This composition enables the 3D fabrication of high-resolution, cell-friendly scaffolds that mimic natural tissue environments, supporting cell growth and tissue engineering applications.

Use CasesContent extracted from patent full text and abstract with AI.

  • Fabrication of custom tissue engineering scaffolds for regenerative medicine.
  • Creation of organ-mimicking in vitro models for drug screening and disease studies.
  • Manufacturing of biocompatible implants tailored to patient-specific anatomies.
  • Production of permeable, cell-adhesive materials for lab-on-chip devices or organ-on-chip platforms.
  • Development of advanced cell culture substrates that better replicate physiological conditions.

BenefitsContent extracted from patent full text and abstract with AI.

  • Enables high-resolution 3D printing of hydrated, biocompatible scaffolds suitable for cell adhesion and growth.
  • Provides improved control over scaffold permeability and mechanical properties through customizable resin composition.
  • Supports the fabrication of complex, biomimetic structures that closely mimic native tissue microarchitecture.
  • Minimizes issues of solvent evaporation and inconsistent polymer concentration during printing, ensuring reproducibility and accuracy.
  • Expands the range of materials (e.g., dECM, functionalized biopolymers) compatible with SLA-based 3D printing, opening new avenues in biofabrication.

Technical Classifications (CPCs)

Main Classifications

Chemistry & Materials Science

Health, Food & Consumer Tech

Manufacturing & Transport

Sub Classifications

Additive Manufacturing

Biochemistry, Beer & Spirits

Medical & Vet Science

Working Plastics & Substances

CPC Codes

A61L27/16A61L27/18A61L27/222A61L27/26A61L27/3633A61L27/50B29C64/129B29C64/40B33Y70/00B33Y80/00C12N5/0068

Inventors & Applicants

Applicants

Univ Berlin Freie

Patent Abstract

The present invention relates to a photocurable composition for 3D printing, comprising a) at least one photocurable prepolymer chosen from the group consisting of functionalized gelatin bearing a first functional group and functionalized decellularized extracellular matrix bearing a second functional group; b) at least one solvent, the solvent being formamide; and c) at least one photoinitiator.

Key Information

Publication No.

EP3771471A1

Family ID

67514451

Publication Date

2021-02-03

Application No.

EP19189493A

Application Date

2019-07-31

Priority Date

2019-07-31

Granted

Yes (1/5)

Possible Cooperation

For further information please contact the transfer office.